Regional and time-dependent effects of inflammatory mediators on airway microvascular permeability in the guinea pig
- PMID: 2721114
- DOI: 10.1042/cs0760479
Regional and time-dependent effects of inflammatory mediators on airway microvascular permeability in the guinea pig
Abstract
1. Airway oedema resulting from increased microvascular permeability is a characteristic pathological finding of asthma. The regional effects of putative mediators involved in asthma on airway microvascular permeability have been studied. 2. The effects of histamine, leukotriene (LT) D4 and platelet-activating factor (PAF) on microvascular permeability in the nasal mucosa, larynx, trachea, main bronchi and intrapulmonary airways of the guinea pig were assessed by measuring the extravasation of intravenously administered Evans Blue dye. 3. PAF and LTD4 caused increased microvascular leakage throughout the respiratory tract, although their effects were maximal in different regions. Histamine had no significant effect on intrapulmonary airways. PAF was more potent than LTD4 and histamine at all airway levels. For example, in the trachea the doses required to cause leakage of 50% of maximal (ED50) were 10.4 nmol/kg, 138 nmol/kg and 11.2 mumol/kg, respectively, for PAF, LTD4 and histamine. 4. The effect of the three mediators was maximal 5 min after intravenous administration. Histamine, but neither LTD4 nor PAF, still caused significant leakage 30 min after administration. 5. The increased microvascular leakage induced by the mediators was inhibited by their respective specific receptor antagonists, suggesting that the effect was mediated via specific receptors. 6. Histamine, LTD4 and PAF have varying potencies in increasing microvascular permeability in the guinea-pig respiratory tract, exert their maximal effect in different regions and have varying durations of action.
Similar articles
-
Formoterol and salbutamol inhibit bradykinin- and histamine-induced airway microvascular leakage in guinea-pig.Br J Pharmacol. 1992 Apr;105(4):792-8. doi: 10.1111/j.1476-5381.1992.tb09059.x. Br J Pharmacol. 1992. PMID: 1354535 Free PMC article.
-
Mechanism of airway narrowing caused by inhaled platelet-activating factor. Role of airway microvascular leakage.Am Rev Respir Dis. 1991 Jun;143(6):1345-9. doi: 10.1164/ajrccm/143.6.1345. Am Rev Respir Dis. 1991. PMID: 2048823
-
Effects of cromakalim on bradykinin-, histamine- and substance P-induced airway microvascular leakage in the guinea-pig.Eur J Pharmacol. 1993 Aug 3;239(1-3):119-26. doi: 10.1016/0014-2999(93)90984-p. Eur J Pharmacol. 1993. PMID: 7693487
-
Mechanisms of increased airway microvascular permeability: role in airway inflammation and obstruction.Clin Exp Pharmacol Physiol. 1995 Jun-Jul;22(6-7):387-96. doi: 10.1111/j.1440-1681.1995.tb02028.x. Clin Exp Pharmacol Physiol. 1995. PMID: 8582087 Review.
-
A current review on animal models of anti-asthmatic drugs screening.Front Pharmacol. 2025 Jan 28;16:1508460. doi: 10.3389/fphar.2025.1508460. eCollection 2025. Front Pharmacol. 2025. PMID: 39981184 Free PMC article. Review.
Cited by
-
Pharmacological modulation of inhaled sodium metabisulphite-induced airway microvascular leakage and bronchoconstriction in the guinea-pig.Br J Pharmacol. 1992 Oct;107(2):481-7. doi: 10.1111/j.1476-5381.1992.tb12771.x. Br J Pharmacol. 1992. PMID: 1330180 Free PMC article.
-
Effects of two novel tachykinin antagonists, FK224 and FK888, on neurogenic airway plasma exudation, bronchoconstriction and systemic hypotension in guinea-pigs in vivo.Br J Pharmacol. 1993 Mar;108(3):844-51. doi: 10.1111/j.1476-5381.1993.tb12888.x. Br J Pharmacol. 1993. PMID: 7682142 Free PMC article.
-
Advancing Obstructive Airway Disease Treatment: Dual PDE3/4 Inhibition as a Therapeutic Strategy.Cells. 2025 Apr 30;14(9):659. doi: 10.3390/cells14090659. Cells. 2025. PMID: 40358183 Free PMC article. Review.
-
Role of histamine and platelet-activating factor in allergic rhinitis.J Physiol Biochem. 2004 Jun;60(2):101-11. doi: 10.1007/BF03168446. J Physiol Biochem. 2004. PMID: 15457928 Review.
-
Leukotriene receptors as potential therapeutic targets.J Clin Invest. 2018 Jul 2;128(7):2691-2701. doi: 10.1172/JCI97946. Epub 2018 May 14. J Clin Invest. 2018. PMID: 29757196 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources